Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Filtricine
AddedFeb 15, 2024
UpdatedJul 16, 2026
Filtricine

Filtricine

Filtricine: A clinical-stage biotech firm innovating nutrient modulation tech for cancer management.

HQ
Santa Clara, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Filtricine, founded as a clinical-stage biotech company, is dedicated to revolutionizing cancer care through its innovative nutrient modulation technology. The company's core mission is to help patients manage cancer by developing proprietary targeted nutrient deprivation (TND) technology. Filtricine's primary product, Tality, is a groundbreaking food product currently under clinical investigation aimed at starving tumors while nourishing the body. The company focuses on providing advanced therapeutic options for cancer patients, addressing a significant unmet need in oncology.

Notable affiliated individuals and investors include leading experts in biotechnology and oncology, although specific names are not publicly disclosed. Filtricine has achieved key milestones, such as advancing Tality into clinical trials, demonstrating its potential efficacy in cancer treatment. The overall impact of Filtricine's work lies in its innovative approach to cancer management, offering a novel dietary-based therapy that could complement existing treatments and improve patient outcomes.

Filtricine - Similar Companies

Faeth Therapeutics logo

Faeth Therapeutics

TumorGen logo

TumorGen

tumorgen.net

Nested Therapeutics logo

Nested Therapeutics

nestedtx.com

Food FiXR logo

Food FiXR

foodfixr.com

Teclison logo

Teclison

teclison.com

Palm Therapeutics logo

Palm Therapeutics

BlinkBio logo

BlinkBio

blinkbioinc.com

Geneius logo

Geneius

geneius.com

Curie.Bio logo

Curie.Bio

curie.bio

Empiri logo

Empiri

empiricancer.com

Cybrexa logo

Cybrexa

cybrexa.com

Remedy Plan logo

Remedy Plan

remedyplan.com

Divide & Conquer logo

Divide & Conquer

Biotechonomy logo

Biotechonomy

Juvenescence logo

Juvenescence

juvlabs.com

Filtricine - Quick Facts

Who are Filtricine's competitors?

Companies similar to Filtricine include Faeth Therapeutics, TumorGen, Nested Therapeutics and Food FiXR.

When was Filtricine founded?

Filtricine was founded in 2017.

Where is Filtricine's headquarters located?

Filtricine's headquarters is located in Santa Clara, CA, US.

How much has Filtricine raised to-date?

As of Aug 29, 2022, Filtricine has raised a total of $5.3M (USD).

How many employees does Filtricine have?

Filtricine has 30 employees as of Feb 4, 2024.

Filtricine - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Food Product
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified